Balance sheet of Beryl Drugs is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Beryl Drugs is decreasing.
Latest net debt of Beryl Drugs is ₹3.26 Crs as of Mar-25.
This is less than Mar-24 when it was ₹4.75 Crs.

The profit is oscillating.
The profit of Beryl Drugs is ₹0.77 Crs for Mar 2024, ₹0.77 Crs for Mar 2023 and -₹0.66 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Beryl Drugs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory, Accounts Receivable